Ultra-Sensitive Biomarker Detection from Discovery to the Clinic

Join the Quanterix team at MBC BioLabs for an in-depth session on how Simoa® technology is focused on accelerating biomarker discovery through ultra-sensitive protein detection, custom assay development, and translational research support. This session will highlight how biotech teams are using Quanterix Accelerator Lab services to develop and validate custom biomarker assays, generate high sensitivity protein data, and transition assays onto the Simoa SR-X platform.

Hosted in partnership with MBC BioLabs

This Simoa Session is hosted in partnership with MBC BioLabs and features Quanterix speakers sharing practical approaches for moving biomarker questions into scalable research workflows.

What We’ll Cover

• The capabilities and workflows of the Quanterix Accelerator Lab
• Translating assay development on the Simoa SR-X for onsite use
• Applications in translational research, immunology, neurology, oncology, and more
• Custom assay development and biomarker strategy support
• Interactive Q&A with the Quanterix scientific team

Discover how Simoa technology can accelerate biomarker discovery and support translational research from assay development to implementation. Reserve your spot today to take your research further.